Profiel
Misako Nakata is the Head-Intellectual Property Counsel at VLP Therapeutics LLC, a company she founded in 2012.
She is also the Chief Intellectual Property Officer & EVP at Sucampo Pharma LLC, where she has been working since 2004 and currently holds a position.
Actieve functies van Misako Nakata
Bedrijven | Functie | Begin |
---|---|---|
Sucampo Pharma LLC
Sucampo Pharma LLC Miscellaneous Commercial ServicesCommercial Services Sucampo Pharma LLC engages in the pharmaceutical product development. It develops the naturally occurring compound prostones, including lubiprostone under the brand Amitiza, which is used for the treatment of chronic constipation, chronic idiopathic constipation (CIC) in adults, and irritable bowel syndrome with constipation (IBS-C). The company is headquartered in Osaka, Japan. | Corporate Officer/Principal | 01-06-2004 |
VLP Therapeutics LLC
VLP Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services VLP Therapeutics LLC operates as a biopharmaceutical company. The firm focuses on developing preventative and therapeutic vaccines, as well as next generation targeted antibody agents to treat cancer and infectious diseases, such as malaria, dengue fever, zika virus-based diseases, and autoimmune. The company was founded by Wataru Akahata, Ryuji Ueno, Sachiko Kuno, Kei S. Tolliver and Misako Nakata in 2012 and is headquartered in Gaithersburg, MD. | Oprichter | 01-01-2012 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Sucampo Pharma LLC
Sucampo Pharma LLC Miscellaneous Commercial ServicesCommercial Services Sucampo Pharma LLC engages in the pharmaceutical product development. It develops the naturally occurring compound prostones, including lubiprostone under the brand Amitiza, which is used for the treatment of chronic constipation, chronic idiopathic constipation (CIC) in adults, and irritable bowel syndrome with constipation (IBS-C). The company is headquartered in Osaka, Japan. | Commercial Services |
VLP Therapeutics LLC
VLP Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services VLP Therapeutics LLC operates as a biopharmaceutical company. The firm focuses on developing preventative and therapeutic vaccines, as well as next generation targeted antibody agents to treat cancer and infectious diseases, such as malaria, dengue fever, zika virus-based diseases, and autoimmune. The company was founded by Wataru Akahata, Ryuji Ueno, Sachiko Kuno, Kei S. Tolliver and Misako Nakata in 2012 and is headquartered in Gaithersburg, MD. | Commercial Services |